Pfizer PBC 125 (Ibrance 125 mg)
Generic Name: palbociclib
Pill with imprint Pfizer PBC 125 is Purple, Elliptical/Oval and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc.
Ibrance is used in the treatment of breast cancer, metastatic; liposarcoma; breast cancer; breast cancer, male and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer PBC 125
Ibrance
- Generic Name
- palbociclib
- Imprint
- Pfizer PBC 125
- Strength
- 125 mg
- Color
- Purple
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- CDK 4/6 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0688
Related images for "Pfizer PBC 125"
More about Ibrance (palbociclib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (68)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: CDK 4/6 inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.